(FY)Jun 30, 2021 | (FY)Jun 30, 2020 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | 0.00%50K | 50K |
Other cash income from operating activities | 0.00%50K | --50K |
Cash paid | 7.69%-1.51M | -1.64M |
Payments to suppliers for goods and services | 7.69%-1.51M | ---1.64M |
Direct interest received | -72.50%22K | --80K |
Operating cash flow | 4.51%-1.44M | ---1.51M |
Investing cash flow | ||
Cash flow from continuing investing activities | -136.26%-1.48M | -626K |
Capital expenditure reported | -137.08%-1.48M | ---623K |
Net PPE purchase and sale | 33.33%-2K | ---3K |
Cash from discontinued investing activities | ||
Investing cash flow | -136.26%-1.48M | ---626K |
Financing cash flow | ||
Cash flow from continuing financing activities | 31,025.00%11.21M | 36K |
Net common stock issuance | 26,652.38%11.24M | --42K |
Net other financing activities | -416.67%-31K | ---6K |
Cash from discontinued financing activities | ||
Financing cash flow | 31,025.00%11.21M | --36K |
Net cash flow | ||
Beginning cash position | -33.41%4.17M | --6.27M |
Current changes in cash | 494.71%8.29M | ---2.1M |
Effect of exchange rate changes | -180.00%-4K | --5K |
End cash Position | 198.39%12.46M | --4.17M |
Free cash from | -36.77%-2.92M | ---2.14M |
Accounting Standards | US-GAAP | US-GAAP |
No Data